Back to search
FDAFDA · Food and drugs·Recall number D-1348-2015

univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.

Published August 26, 2015 · Recall initiated: July 24, 2015

Summary

FDA records drug Class II recall D-1348-2015, published August 26, 2015 and initiated July 24, 2015. Recalling firm: Ucb, Inc; Status: Terminated; Reported quantity: 2,916 Bottles; Lot: Lot #: 98016P1, Expiry: April, 2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Testing: Failed 24 month dissolution testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ucb, Inc
Distributor
U.S. Nationwide
Lot
Lot #: 98016P1, Expiry: April, 2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01. recalled?

Yes. FDA published recall D-1348-2015 on August 26, 2015. Reported hazard: Failed Dissolution Testing: Failed 24 month dissolution testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter